|
IL-9
|
2.7E−07
|
1.4E−04
|
−46.7
|
Interleukin 9
|
|
GZMK
|
9.7E−05
|
3.9E−03
|
−17.1
|
Granzyme K (granzyme 3; tryptase II)
|
|
IFN-γ
|
8.5E−04
|
1.5E−02
|
−16.7
|
Interferon gamma
|
|
CCL5
|
3.8E−05
|
2.2E−03
|
−11.9
|
Chemokine (C–C motif) ligand 5
|
|
GZMH
|
1.4E−04
|
4.8E−03
|
−11.7
|
Granzyme H (cathepsin G-like 2, protein h-CCPX)
|
|
IL-3
|
2.2E−08
|
2.7E−05
|
−11.2
|
Interleukin 3 (colony-stimulating factor, multiple)
|
|
NKG7
|
8.4E−05
|
3.6E−03
|
−9.1
|
Natural killer cell group 7 sequence
|
|
CCL4L2
|
5.1E−03
|
4.4E−02
|
−7.0
|
Chemokine (C–C motif) ligand 4-like 2
|
|
CCL3
|
5.3E−03
|
4.5E−02
|
−6.8
|
Chemokine (C–C motif) ligand 3
|
|
EOMES
|
2.3E−07
|
1.3E−04
|
−6.6
|
Eomesodermin homolog (Xenopus laevis)
|
|
CCL3L1
|
3.9E−03
|
3.8E−02
|
−6.5
|
Chemokine (C–C motif) ligand 3-like 1
|
|
CCL3L3
|
5.2E−03
|
4.5E−02
|
−6.3
|
Chemokine (C–C motif) ligand 3-like 3
|
|
NAPSB
|
2.7E−03
|
3.0E−02
|
−6.1
|
Homo sapiens napsin B aspartic peptidase pseudogene (NAPSB)
|
|
BATF3
|
2.5E−08
|
2.8E−05
|
−5.9
|
Basic leucine zipper transcription factor, ATF-like 3
|
|
NAPSA
|
3.1E−04
|
7.9E−03
|
−5.6
|
Napsin A aspartic peptidase
|
|
CXCR3
|
4.2E−04
|
9.7E−03
|
−5.2
|
Chemokine (C–X–C motif) receptor 3
|
|
MATK
|
1.9E−07
|
1.2E−04
|
−4.9
|
Megakaryocyte-associated tyrosine kinase, transcript variant 3
|
|
OSM
|
2.5E−06
|
4.7E−04
|
−4.3
|
Oncostatin M
|
|
IRF8
|
2.5E−05
|
1.7E−03
|
−4.2
|
Interferon regulatory factor 8
|
|
MAOA
|
3.0E−04
|
7.8E−03
|
−4.0
|
Monoamine oxidase A, nuclear gene encoding mitochondrial protein
|
|
DNAJC12
|
5.1E−04
|
1.1E−02
|
−3.9
|
DnaJ (Hsp40) homolog. subfamily C, member 12
|
|
MT1 J
|
6.1E−06
|
7.1E−04
|
−3.9
|
Metallothionein 1G
|
|
NPSR1
|
1.5E−05
|
1.2E−03
|
−3.9
|
Neuropeptide S receptor 1, transcript variant 1
|
|
ATP8B4
|
4.0E−05
|
2.2E−03
|
−3.8
|
ATPase. class I, type 8B. member 4
|
|
TIMD4
|
1.8E−05
|
1.4E−03
|
−3.8
|
T-cell immunoglobulin and mucin domain containing 4
|
|
LTA
|
3.8E−05
|
2.2E−3
|
−3.7
|
Lymphotoxin alpha (TNF superfamily. member 1)
|
|
SERPINB6
|
2.1E−07
|
1.3E−04
|
−3.2
|
Serpin peptidase inhibitor, clade B (ovalbumin). member 6
|
|
PTK2
|
5.1E−03
|
4.4E−02
|
−2.7
|
PTK2 protein tyrosine kinase 2, transcript variant 2
|
|
CCL17
|
2.3E−05
|
1.6E−03
|
−2.6
|
Chemokine (C–C motif) ligand 17
|
|
NFIL3
|
3.4E−03
|
3.5E−02
|
−2.5
|
Nuclear factor interleukin 3 regulated
|
